Literature DB >> 20626764

Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.

Stefanie Salvenmoser1, Marc J Seidler, Alexander Dalpke, Frank-Michael C Müller.   

Abstract

The possible involvement of Toll-like receptors (TLRs) 1, 2, 4 and 9 in the interaction of antifungal drugs with polymorphonuclear neutrophils (PMNs) in response to Aspergillus fumigatus and Candida albicans as stimuli was investigated. Caspofungin revealed the broadest capacity to enable C. albicans and A. fumigatus to stimulate TLR upregulation, TLR 2 by A. fumigatus and TLRs 4, 9 by C. albicans. Conventional amphotericin B (cAMB) stimulated only A. fumigatus to induce TLRs 2 and 4 upregulation; voriconazole stimulated A. fumigatus and fluconazole C. albicans to induce TLR 9 upregulation. For cAMB, only TLR 9 was upregulated by A. fumigatus, whereas in the case of voriconazole, TLRs 2, 4, 9 were upregulated. Caspofungin revealed the broadest capacity: C. albicans was stimulated to upregulate TLRs at least at one of the concentrations, and A. fumigatus was stimulated to upregulate TLRs 2, 4. TLR 9 was upregulated two to three fold by all antifungal drugs on protein, except for fluconazole at the RNA level. Candida albicans preincubated with caspofungin has additional effects on CD11b expression and IL8 chemotaxis in CpG-DNA-stimulated PMNs. These results indicate a relevant upregulation with a functional relevance of TLR 9 in the presence of C. albicans strains preincubated with caspofungin at three concentrations.
© 2010 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626764     DOI: 10.1111/j.1574-695X.2010.00720.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

1.  Role of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.

Authors:  Silvia Moretti; Silvia Bozza; Carmen D'Angelo; Andrea Casagrande; Maria Agnese Della Fazia; Lucia Pitzurra; Luigina Romani; Franco Aversa
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.

Authors:  Xuelian Wang; Hannah N Coleman; Uma Nagarajan; Horace J Spencer; Mayumi Nakagawa
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

Review 3.  The impact of antifungals on toll-like receptors.

Authors:  Mircea R Mihu; Rodney Pattabhi; Joshua D Nosanchuk
Journal:  Front Microbiol       Date:  2014-03-14       Impact factor: 5.640

Review 4.  Fungal pathogens-a sweet and sour treat for toll-like receptors.

Authors:  Christelle Bourgeois; Karl Kuchler
Journal:  Front Cell Infect Microbiol       Date:  2012-11-22       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.